Influence of Main Risk Factors on the Incidence of VOD in the Patients Included in This Survey
| . | KI >90 and Normal AST . | >AST . | KI <90 . | >AST + KI <90 . |
|---|---|---|---|---|
| AutoBMT | ||||
| Low-dose CT | 0.9% | 14.3% | 0% | NC |
| High-dose CT | 3.3% | 6.8% | 11.1% | 28.6% |
| AlloBMT | ||||
| Low-dose CT | 3.9% | 25% | NC | NC |
| High-dose CT | 7.5% | 11.4% | 25% | NC |
| . | KI >90 and Normal AST . | >AST . | KI <90 . | >AST + KI <90 . |
|---|---|---|---|---|
| AutoBMT | ||||
| Low-dose CT | 0.9% | 14.3% | 0% | NC |
| High-dose CT | 3.3% | 6.8% | 11.1% | 28.6% |
| AlloBMT | ||||
| Low-dose CT | 3.9% | 25% | NC | NC |
| High-dose CT | 7.5% | 11.4% | 25% | NC |
Abbreviations: CT, cytoreductive therapy; KI, Karnofsky performance score; AST, aspartate aminotransferase; NC, no cases presented these risk factors.